Sonendo, Inc.
General ticker "SONX" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $4.4M (TTM average)
Sonendo, Inc. does not follow the US Stock Market performance with the rate: -33.9%.
Estimated limits based on current volatility of 6.2%: low 0.21$, high 0.23$
Factors to consider:
- Total employees count: 216 (-17.2%) as of 2023
- Top business risk factors: High operating expenses, Limited commercialization experience, Manufacturing scale up, Product quality issues, Quality control failures
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.76$, 5.03$]
- 2025-12-31 to 2026-12-31 estimated range: [0.29$, 1.93$]
Financial Metrics affecting the SONX estimates:
- Positive: with PPE of -0.0 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -27.93 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: Shareholder equity ratio, % of 16.60 <= 18.93
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
Short-term SONX quotes
Long-term SONX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $41.66MM | $43.87MM | $31.70MM |
| Operating Expenses | $99.86MM | $101.61MM | $61.07MM |
| Operating Income | $-58.20MM | $-57.74MM | $-29.37MM |
| Non-Operating Income | $1.15MM | $-4.72MM | $-4.17MM |
| Interest Expense | $3.23MM | $3.17MM | $5.47MM |
| R&D Expense | $16.78MM | $10.24MM | $6.76MM |
| Income(Loss) | $-57.05MM | $-62.46MM | $-33.54MM |
| Taxes | $0.00MM | $0.00MM | $0.00MM |
| Profit(Loss)* | $-57.05MM | $-60.92MM | $-28.03MM |
| Stockholders Equity | $81.95MM | $28.42MM | $5.19MM |
| Inventory | $15.46MM | $11.07MM | $10.21MM |
| Assets | $137.28MM | $78.16MM | $31.27MM |
| Operating Cash Flow | $-61.07MM | $-46.06MM | $-24.65MM |
| Capital expenditure | $1.36MM | $0.93MM | $0.16MM |
| Investing Cash Flow | $-74.43MM | $42.40MM | $45.81MM |
| Financing Cash Flow | $68.53MM | $0.00MM | $-24.95MM |
| Earnings Per Share** | $-1.27 | $-0.65 | $-0.59 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.